{
  "id": 9578023,
  "title": "Merck reveals study success, and possible safety worries, for eye drug hopeful",
  "url": "https://urgent.news/2026/09/24/merck-reveals-study-success-and-possible-safety-worries-for-eye-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T15:34:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/merck-remigromig-dme-study-results-eyebio/831234/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, though language regarding the drug’s safety stirred debate among analysts.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}